Hasil Pencarian - Michael Spannagl

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Experiences and challenges for EQA providers in assessing the commutability of control materials in accuracy-based EQA programs

    Experiences and challenges for EQA providers in assessing the commutability of control materials in accuracy-based EQA programs oleh Laura Vierbaum, Patricia Kaiser, Michael Spannagl, Michael Spannagl, Folker Wenzel, Folker Wenzel, Mario Thevis, Ingo Schellenberg, Ingo Schellenberg

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A novel approach to laboratory assessment and reporting of platelet von Willebrand factor

    A novel approach to laboratory assessment and reporting of platelet von Willebrand factor oleh Thorsten Kragh, Isabell Pekrul, Helmut W. Ott, Michael Spannagl, Patrick Möhnle

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer

    Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer oleh Isabell Pekrul, Thorsten Kragh, Peter L Turecek, Aaron R Novack, Helmut W Ott, Michael Spannagl

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

    Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? oleh Luise Goldmann, Rundan Duan, Thorsten Kragh, Georg Wittmann, Christian Weber, Reinhard Lorenz, Philipp von Hundelshausen, Michael Spannagl, Wolfgang Siess

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time

    Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time oleh Rundan Duan, Luise Goldmann, Richard Brandl, Michael Spannagl, Christian Weber, Christian Weber, Christian Weber, Wolfgang Siess, Wolfgang Siess, Philipp von Hundelshausen, Philipp von Hundelshausen

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules.

    Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. oleh Bijan Raziorrouh, Malte Heeg, Peter Kurktschiev, Winfried Schraut, Reinhart Zachoval, Clemens Wendtner, Martin Wächtler, Michael Spannagl, Gerald Denk, Axel Ulsenheimer, Bertram Bengsch, Hanspeter Pircher, Helmut M Diepolder, Norbert H Grüner, Maria-Christina Jung

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: